Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial (vol 29, pg 2825, 2023)

被引：1

作者：

Galsky, Matthew D. ^{[1
,2
]}

Daneshmand, Siamak ^{[3
]}

Izadmehr, Sudeh ^{[1
]}

Gonzalez-Kozlova, Edgar ^{[4
]}

Chan, Kevin G. ^{[5
]}

Lewis, Sara ^{[6
]}

El Achkar, Bassam ^{[6
]}

Dorff, Tanya B. ^{[7
]}

Cetnar, Jeremy Paul ^{[8
]}

Neil, Brock O. ^{[9
]}

D'Souza, Anishka ^{[10
]}

Mamtani, Ronac ^{[11
]}

Kyriakopoulos, Christos ^{[12
]}

Jun, Tomi ^{[13
,25
]}

Gogerly-Moragoda, Mahalya ^{[1
]}

Brody, Rachel ^{[2
,14
]}

Xie, Hui ^{[15
]}

Nie, Kai ^{[15
]}

Kelly, Geoffrey ^{[15
]}

Horowitz, Amir ^{[2
,16
]}

Kinoshita, Yayoi ^{[14
]}

Ellis, Ethan ^{[17
,18
]}

Nose, Yohei ^{[16
]}

Ioannou, Giorgio ^{[16
]}

Cabal, Rafael ^{[16
]}

Del Valle, Diane M. ^{[16
]}

Haines, G. Kenneth ^{[19
]}

Wang, Li ^{[1
,20
]}

Mouw, Kent W. ^{[21
]}

Samstein, Robert M. ^{[22
]}

Mehrazin, Reza ^{[23
]}

Bhardwaj, Nina ^{[2
,15
,16
]}

Yu, Menggang ^{[24
]}

Zhao, Qianqian ^{[24
]}

Kim-Schulze, Seunghee ^{[2
,15
,16
]}

Sebra, Robert ^{[2
,17
,18
]}

Zhu, Jun ^{[1
,20
]}

Gnjatic, Sacha ^{[2
,15
,16
]}

Sfakianos, John ^{[23
]}

Pal, Sumanta K. ^{[7
]}

机构：

[1] Icahn Sch Med Mt Sinai, Div Hematol & Med Oncol, New York, NY 10029 USA

[2] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA

[3] Keck Sch Med USC, Dept Urol, Norris Comprehens Canc Ctr, Los Angeles, CA USA

[4] Icahn Sch Med Mt Sinai, Dept Oncol Sci, Tisch Canc Inst, New York, NY 10029 USA

[5] City Hope Comprehens Canc Ctr, Dept Urol, Duarte, CA USA

[6] Icahn Sch Med Mt Sinai, Dept Radiol, Tisch Canc Inst, New York, NY 10029 USA

[7] City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut, Duarte, CA USA

[8] Oregon Hlth & Sci Univ, Div Hematol & Med Oncol, Portland, OR 97201 USA

[9] Univ Utah, Dept Urol, Salt Lake City, UT USA

[10] Keck Sch Med USC, Div Hematol & Med Oncol, Norris Comprehens Canc Ctr, Los Angeles, CA USA

[11] Univ Penn, Abramson Canc Ctr, Div Hematol & Med Oncol, Philadelphia, PA 19104 USA

[12] Univ Wisconsin, Div Hematol & Med Oncol, Carbone Canc Ctr, Madison, WI USA

[13] Genentech Inc, San Francisco, CA USA

[14] Icahn Sch Med Mt Sinai, Tisch Canc Inst, Dept Pathol, New York, NY 10029 USA

[15] Icahn Sch Med Mt Sinai, Human Immune Monitoring Ctr, New York, NY 10029 USA

[16] Icahn Sch Med Mt Sinai, Precis Immunol Inst, New York, NY 10029 USA

[17] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA

[18] Icahn Sch Med Mt Sinai, Icahn Inst Data Sci & Genom Technol, New York, NY 10029 USA

[19] Icahn Sch Med Mt Sinai, Dept Pathol Mol & Cell Based, New York, NY 10029 USA

[20] Gene Dx, Stamford, CT USA

[21] Harvard Med Sch, Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA

[22] Icahn Sch Med Mt Sinai, Dept Radiat Oncol, Tisch Canc Inst, New York, NY 10029 USA

[23] Icahn Sch Med Mt Sinai, Dept Urol, Tisch Canc Inst, New York, NY 10029 USA

[24] Univ Wisconsin, Carbone Canc Ctr, Dept Biostat & Med Informat, Madison, WI USA

[25] Icahn Sch Med Mt Sinai, New York, NY 10029 USA

来源：

NATURE MEDICINE | 2024年 / 30卷 / 04期

关键词：

D O I：

10.1038/s41591-024-02814-0

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：1211 / 1211

页数：1

共 50 条

[31] Comparative effectiveness of gemcitabine plus cisplatin versus methotrexate, vinblastine, doxorubicin, plus cisplatin as neoadjuvant therapy for muscle-invasive bladder cancer
Galsky, Matthew D.
Pal, Sumanta K.
Chowdhury, Simon
Harshman, Lauren C.
Crabb, Simon J.
Wong, Yu-Ning
Yu, Evan Y.
Powles, Thomas
Moshier, Erin L.
Ladoire, Sylvain
Hussain, Syed A.
Agarwal, Neeraj
Vaishampayan, Ulka N.
Recine, Federica
Berthold, Dominik
Necchi, Andrea
Theodore, Christine
Milowsky, Matthew I.
Bellmunt, Joaquim
Rosenberg, Jonathan E.
CANCER, 2015, 121 (15) : 2586 - 2593
[32] PHASE 2 TRIAL OF NEOADJUVANT GEMCITABINE AND CARBOPLATIN FOR MUSCLE-INVASIVE BLADDER CANCER FOLLOWED BY RADICAL CYSTECTOMY
Koie, Takuya
Okamoto, Teppei
Imanishi, Kengo
Sugiyama, Naoki
Kudoh, Shigemasa
Mori, Kazuyuki
Tachiwada, Tokushi
Yoneyama, Takahiro
Hashimoto, Yasuhiro
Kamimura, Noritaka
Ohyama, Chikara
Suzuki, Yuichiro
JOURNAL OF UROLOGY, 2010, 183 (04): : E657 - E657
[33] Bladder-sparing treatment using tislelizumab combined with gemcitabine/cisplatin in selected patients with muscle-invasive bladder cancer: a real-world study
Luo, Cheng
Luo, Shuhang
Wusimanjiang, Wumier
Wang, Zongren
Liu, Ping
Wang, Bin
Yuan, Dan
Lin, Hao
Xu, Abai
Deng, Nan
Wu, Kaihui
Zhu, Xuejin
Xu, Peng
Chen, Junxing
Huang, Bin
CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (07): : 1759 - 1767
[34] A PHASE 1/2 STUDY OF RAPAMYCIN AND CISPLATIN/GEMCITABINE FOR TREATMENT OF PATIENTS (PTS) WITH MUSCLE-INVASIVE BLADDER CANCER (NCT01938573)
Makrakis, Dimitrios
Roudier, Martine
Wang, Yan
Vakar-Lopez, Funda
Garcia, Jose
Dash, Atreya
Lin, Daniel
Schade, George
Mostaghel, Elahe A.
Cheng, Heather
Schweizer, Michael T.
Holt, Sarah K.
Gore, John L.
Yu, Evan
Lam, Hung-Ming
Wright, Jonathan L.
Montgomery, Bruce
JOURNAL OF UROLOGY, 2022, 207 (05): : E185 - E185
[35] Oncolytic immunotherapy with nivolumab in muscle-invasive bladder cancer: a phase 1b trial
Li, Roger
Villa, Nancy Y.
Yu, Xiaoqing
Johnson, Joseph O.
Borjas, Gustavo
Dhillon, Jasreman
Moran-Segura, Carlos M.
Kim, Youngchul
Francis, Natasha
Dorman, Denise
Powers, John J.
Sexton, Wade J.
Spiess, Philippe E.
Poch, Michael A.
Zemp, Logan
Gilbert, Scott M.
Zhang, Jingsong
Pow-Sang, Julio M.
Anderson, Alexander R. A.
Li, Tingyi
Wang, Xuefeng
Grass, G. Daniel
Burke, James M.
Dinney, Colin P. N.
Rodriguez, Paulo C.
Jain, Rohit K.
Mule, James J.
Conejo-Garcia, Jose R.
NATURE MEDICINE, 2025, 31 (01) : 176 - 188
[36] Phase II trial of neoadjuvant gemcitabine (G) and cisplatin (C) with sunitinib in patients (pts) with muscle-invasive bladder cancer (MIBC)
Balar, Arjun Vasant
Iyer, Gopa
Apolo, Andrea Borghese
Regazzi, Ashley Marie
Garcia-Grossman, Ilana Rebecca
Pendse, Deepa
Ostrovnaya, Irina
Chou, Joanne F.
Bochner, Bernard
Dalbagni, Guido
Herr, Harry W.
Milowsky, Matthew I.
Bajorin, Dean F.
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[37] Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial
Funt, Samuel A.
Lattanzi, Michael
Whiting, Karissa
Al-Ahmadie, Hikmat
Quinlan, Colleen
Teo, Min Yuen
Lee, Chung-Han
Aggen, David
Zimmerman, Danielle
McHugh, Deaglan
Apollo, Arlyn
Durdin, Trey D.
Truong, Hong
Kamradt, Jeffrey
Khalil, Maged
Lash, Bradley
Ostrovnaya, Irina
McCoy, Asia S.
Hettich, Grace
Regazzi, Ashley
Jihad, Marwah
Ratna, Neha
Boswell, Abigail
Francese, Kaitlyn
Yang, Yuanquan
Folefac, Edmund
Herr, Harry W.
Donat, S. Machele
Pietzak, Eugene
Cha, Eugene K.
Donahue, Timothy F.
Goh, Alvin C.
Huang, William C.
Bajorin, Dean F.
Iyer, Gopa
Bochner, Bernard H.
Balar, Arjun V.
Mortazavi, Amir
Rosenberg, Jonathan E.
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (12) : 1312 - +
[38] Efficacy and safety of dose-dense gemcitabine plus cisplatin as neoadjuvant chemotherapy for muscle-invasive bladder cancer
Hattori, Yuto
Fujiwara, Tasuku
Hagimoto, Hiroki
Kokubun, Hidetoshi
Murata, Shiori
Makita, Noriyuki
Abe, Yohei
Kubota, Masashi
Tohi, Yoichiro
Tsutsumi, Naofumi
Shibasaki, Noboru
Inoue, Koji
Kawakita, Mutsushi
Yamasaki, Toshinari
INTERNATIONAL JOURNAL OF UROLOGY, 2024, 31 (10) : 1102 - 1106
[39] Neoadjuvant sintilimab combined with gemcitabine and cisplatin (GP) for muscle-invasive bladder cancer (MIBC) patients followed by selective bladder sparing surgery
Tong, Z.
Fu, G.
Zhou, F.
Liu, X.
Xue, X.
Zhang, H.
Wang, Y.
Zhu, X.
Gao, Y.
Liu, L.
Bao, X.
Zheng, Y.
Fang, W.
Zhao, P.
Jin, B.
ANNALS OF ONCOLOGY, 2023, 34 : S1210 - S1210
[40] Role of adjuvant intravesical chemotherapy in the combined organ-sparing treatment of non-muscle-invasive bladder cancer
Zubkov, A. Yu.
Nuriev, I. R.
Sitdykov, E. N.
ONKOUROLOGIYA, 2014, 10 (02): : 26 - 28

← 1 2 3 4 5 →